Login
Theme

About

Created in 2019, the CIML Genomics Platform provides the institute's researchers and scientific staff with cutting-edge technologies in transcriptomics and genomics, as well as dedicated expertise to support their projects. The platform is composed of scientific director Pierre Milpied (Inserm Research Director) and Laurine Gil (CNRS Study Engineer).  

In 2024, the platform obtained the “Aix-Marseille Platform” quality label for a period of three years, issued by Aix Marseille University, Inserm and CNRS.

The missions of the CIML Genomics platform are:

  • Provide and maintain the necessary equipment: The genomics platform provides material and technological support by making various equipment available.
  • Train users : the platform offers training to users, allowing them to master the techniques necessary for their scientific projects.
  • Supporting experiments : the platform offers experimental support to assist users during complex manipulations, thus ensuring the quality and precision of experiments.
  • Develop new methods : continuous technological monitoring allows us to offer the most recent innovations and make available protocols based on bulk RNA-seq or single-cell RNA-seq technologies.
  • Assist with experimental design : the platform helps users to best define their experimental design, in close collaboration with the CIML CB2M (Computational Biology, Biostatistics and Modeling) platform.
  • Carry out projects : the platform offers to fully support certain genomics experiments to meet the specific needs of research projects (library preparation, sequencing).

Our Services

The genomics platform supports users throughout their projects, from experimental design to sequencing data acquisition, ensuring scientific rigor and technical quality. This support is offered through various services:

  • Experimental design : the platform provides advice and support in defining experimental design, in close coordination with all the other CIML platforms involved.
  • Training and experimental support : the platform assists users in carrying out complex experiments, ensuring the reliability and reproducibility of experiments.
  • Access to genomics equipment : the platform provides a wide range of instruments (thermal cyclers, qPCR devices, Agilent TapeStation, Chromium X).
  • Preparation of single-cell RNA-seq libraries : the platform supports the preparation of single-cell RNA-seq libraries at the request of project leaders.
  • High-throughput sequencing : the platform ensures the sequencing of libraries on the Illumina NextSeq 2000 sequencer.

Our Technologies

We have advanced expertise and the necessary equipment to perform multi-omic analyses on single cells after droplet capture (10x Genomics technology): single-cell RNA-seq, CITE-seq, single-cell BCR-seq, single-cell TCR-seq.

We are also experts in the single-cell multi-omic analysis technology FB5P-seq (FACS-based 5′-end sequencing), developed at CIML, and enabling the integrative analysis (phenotype, transcriptome, BCR or TCR repertoire) of rare cells sorted by FACS.

We provide the necessary equipment for the preparation and quality control of sequencing libraries for any type of protocol, and we perform the sequencing of compatible libraries on our Illumina NextSeq2000 high-throughput sequencer.

We have a fleet of 4 real-time quantitative PCR equipment, compatible with 96-well or 384-well formats.

Training

The genomics platform provides training activities at two levels:

  • Within the CIML, by providing staff training in techniques related to the preparation of single-cell RNAseq libraries.
  • Nationally, with Inserm training “Single-cell RNAseq analyses”, organized once or twice a year in collaboration with the CIML CB2M platform.

Projects

Project
2025
Treating Breast Cancer

Project: Treating Breast Cancer Breast cancer is the most frequently diagnosed cancer in women in […]

Emilie NARNI-MANCINELLI
Project
2025
Treating Liver Metastases

Project: TREATLIVMETS Liver metastases occur in nearly 50% of cancer patients, particularly in […]

Eric VIVIER
Project
2025
Role of plasmacytoid dendritic cells in disease-associated behavior (DC) induced during viral infections or obesity (pDCComp)

Project: pDCComp Individuals infected with viruses or suffering from inflammatory diseases develop a set of behavioral disorders […]

Elena TOMASELLO
Project
2025
Role of interactions with dendritic cells in maintaining NK cell functions in tumor conditions

Project: PLBIO 2024 Coordinator: Thierry Walzer, CIRI, Lyon. Other participant: Nathalie Bendriss-Vermare, CRCL, Lyon. Abstract: Natural Killer cells […]

Marc DALOD
Project
2025
To determine how dendritic cells promote effective anti-tumor NK and CD8 T responses in mouse models of breast cancer, spontaneously or in response to adjuvant administration

Project: ACLAMADABREC Partly through their effectiveness in activating natural killer (NK) cells and CD8 T lymphocytes […]

Marc DALOD
Project
2025
Computational deciphering and mathematical modeling of regulatory networks controlling plasmacytoid dendritic cell biology

Project: MITI Other participants: Magali Richard, LIG, Grenoble; Lionel Spinelli, CB2M hub of CIML. Summary: This project aims to […]

Marc DALOD
Project
2025
Accelerating our ability to understand and combat immunopathology caused by respiratory infections due to emerging viruses: from mouse models to patients to macaques

Project: UNFIRE Other participants: Ciphe (Ana Zarubica), Hospices Civils de Lyon and CIRI (Sophie Trouillet-Assant, Thierry Walzer), CoVir team […]

Marc DALOD
Marc BAJENOFF
Rejane RUA
Mauro GAYA
Philippe PIERRE
Project
2025
Contributions of non-coding genome-derived antigens to anti-tumor immune responses.

Project: PLBIO-25 Coordinator: Marianne BURBAGE, Institut Curie, Paris. Other participant: Andrew GRIFFITHS, ESPCI, Paris. The effectiveness of CD8 T lymphocytes […]

Nathalie AUPHAN-ANEZIN, PhD, HDR
Project
2025
A novel genetic screening approach to identify regulators of the biology of different types of human dendritic cells

Project: DCFUNDEVSCREEN Abstract: Studies in mice have shown the key antiviral/tumor role of plasmacytoid dendritic cells (pDCs) […]

Marc DALOD
Project
2025
Role of type I interferons and plasmacytoid dendritic cells in pulmonary immunopathology caused by respiratory viral infections

Project: RIPIREVI Other participants: CIPHE (Ana Zarubica and colleagues). Abstract: Type I interferons (IFN-Is) are essential for […]

Marc DALOD
Rejane RUA
Project
2025
LYMPHOMATLAS: an atlas of B-cell lymphomas at the single-cell level

Project: LYMPHOMATLAS Single-cell multi-omic studies in B-lymphomas have highlighted a […]

Sandrine ROULLAND
Pierre MILPIED
Project
2025
Discovery of a novel TSLP-induced regulatory axis in the pathogenesis of inflammatory skin diseases

Project: NRegSkin Project leader: Mei LI (IGBMC, Strasbourg). Other participants: Katia Boniface, Julien Seneschal (University of Bordeaux). Summary: The skin […]

Marc DALOD
Project
2025
CPC_profile: Characterization and Targeting of Cancer Precursor Cells (CPC) at the origin of relapses in B-cell lymphomas 

The progression of follicular lymphoma is marked by iterative cycles of remission and relapse, the latter usually resulting from the […]

Sandrine ROULLAND
Project
2025
Intracellular Carriers Against Resistant microOrganisms (ICARO)

Project: ICARO Current acellular vaccines are mostly effective against extracellular pathogens, but fail to induce a response […]

Hugues LELOUARD
Cyrille MIONNET
Project
2025
T-Mac 

Project: T-MAC The T-MAC project aims to understand how testicular macrophages and their niches contribute to the maintenance of […]

Marc BAJENOFF
Project
2025
Role of Border-Associated Macrophages in meningioma and stroke

Project: DeCoDis In the context of a European consortium, we are investigating the dynamics and function of border-associated macrophages […]

Rejane RUA
Project
2025
Identification of oncogenic dependencies and response mechanisms to targeted therapies in B-cell lymphomas

In order to identify new therapeutic combinations and understand the mechanisms of resistance to targeted therapies in lymphoid-derived hemopathies […]

Sandrine ROULLAND
Project
2025
Validation, adaptation and development in clinical routine of a single-cell biomarker stratifying high-risk FL patients

Patients with follicular lymphoma (FL) present a very high biological heterogeneity, which strongly impacts the response to current therapies. […]

Sandrine ROULLAND
Project
2025
TALETE (Transcan-3 ERA-NET, Europe)

Targeting acute myeloid leukemia immunosuppressive microenvironment by combined IDO1 inhibition and PD-1 blockade Type: European.Duration: 2023–2027 (36 months).Partners & funding […]

Rafael J ARGUELLO
Project
2025
Neuroimmune regulations and viral infection

The host response to pathogens is orchestrated by the immune system and the nervous system, both present in […]

Sophie UGOLINI
Project
2025
Regulation of inflammation by the neurokine TAFA4

We have demonstrated that the neurokine TAFA4, produced by sensory neurons in the skin, can promote tissue repair […]

Sophie UGOLINI
Project
2025
Sensory neurons and immune regulation

Beyond the pain perception processes that are induced in the event of injury or infection of the […]

Sophie UGOLINI
Project
2025
Epic-SCENITH: regulators of metabolism and epigenetics in glioblastoma-associated myeloid cells

Duration: 2021–2025.Partners & funding amounts: APHM/La Timone (E. Tabouret); amount for team: 325 k€.Responsibilities: PI–coordinator (only beneficiary)Theme & content of […]

Rafael J ARGUELLO
Project
2025
Biomarkers established to stratify sepsis long-term adverse effects to improve patients' survivorship (BEATsep)

Full title & acronym: Biomarkers established to stratify sepsis long-term adverse effects to improve patients' survivorship (BEATsep).Duration: 2024–2029 (60 months).Partners […]

Rafael J ARGUELLO
Project
2025
TCELL-CODE: Deciphering T cell activation through TCR stimulation dynamics

The TCELL-CODE project, coordinated by Dr. Rémy Lasserre at the Marseille Cancer Research Center, aims to elucidate […]

Pierre MILPIED
Guillaume VOISINNE
Project
2025
PLAIR: Deciphering the hepatic immune response in autoimmune diseases

The PLAIR project, coordinated by Dr Amédée Renand (CR2TI, Nantes), aims to identify the molecular pathways controlling the response […]

Pierre MILPIED
Project
2025
LUCA-pi: Immunogenomic biomarkers for the prevention and interception of lung cancer

The University Hospital Research (RHU) project LUCA-pi (Lung Cancer prevention and interception), coordinated by Professor David Boulate (AP-HM), aims […]

Pierre MILPIED
Project
2025
GCselection: Redefining the selection criteria for B lymphocytes in germinal centers

The GCselection project, coordinated by Dr. Pierre Milpied (CIML), revisits the mechanisms of antibody maturation in centers […]

Pierre MILPIED
Mauro GAYA
Project
2025
AITLas-Impact: Deciphering the heterogeneity of angioimmunoblastic T-cell lymphomas

The AITLas-Impact project, coordinated by Pierre Milpied (CIML) in collaboration with Professor François Lemonnier (Mondor Institute of Biomedical Research, […]

Pierre MILPIED
Project
2025
CLL-PID: Familial chronic lymphocytic leukemia and immune deficiencies

Dr. Pierre Milpied's team at CIML is participating in a collaborative project coordinated by Dr. Jean-Pierre de Villartay (Institut […]

Pierre MILPIED